IMUX — Immunic Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Immunic Inc

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$11.55
Market Cap$172M
Float10.5M
Shares Outstanding13.6M
vs. Analyst Target+331.8% to analyst PT
Dividend RateNone
Analyst Target Price$49.88 (7 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$44.0M -$39,000 -$48.9M
2021 N/A -$92.8M -$85,000 -$91.6M
2022 N/A -$120M -$77,000 -$86.4M
2023 N/A -$93.6M -$111,000 -$99.1M
2024 N/A -$101M -$134,000 -$97.9M
2025 N/A -$97.2M -$168,000 -$97.0M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$26.8M
Sep 2025 N/A -$25.6M
Dec 2025 N/A -$19.3M
Mar 2026 N/A -$32.6M

Ownership & Float

Insider Ownership1.0%
Institutional Ownership49.5%
Short Float12.7%
% of All Funds Holding0.82%
Number of Funds Holding67

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$10.89Near-term / short-term trend
Weekly40-Week SMA$8.65Medium-term trend
Weekly80-Week SMA$9.33Cyclical trend (business cycle)
Weekly200-Week SMA$14.73Secular trend (multi-year)
Monthly10-Month SMA$8.60Near-term monthly trend
Monthly20-Month SMA$9.30Medium-term monthly trend
Monthly40-Month SMA$12.34Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$6.30 support 2.89x 2 months ago
$12.50 resistance 1.62x 16 months ago
$16.50 resistance 1.81x 18 months ago

Historical Earnings Reactions (49 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 1.19% 0.05% 51.02% 27.44% -5.98%
1 Day 1.23% -1.02% 44.90% 27.91% -16.04%
1 Week 4.68% 2.70% 53.06% 52.37% -21.92%
2 Weeks 6.24% 2.51% 54.17% 167.17% -25.93%
1 Month 3.45% -2.19% 45.83% 113.97% -75.97%

Next earnings: May 21, 2026

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan6.1%50.0%12
Feb6.1%41.7%12
Mar-3.4%33.3%12
Apr2.6%25.0%12
May-9.4%8.3%12
Jun13.5%58.3%12
Jul5.4%58.3%12
Aug-4.2%58.3%12
Sep-7.3%50.0%12
Oct-3.5%33.3%12
Nov-0.2%50.0%12
Dec2.1%58.3%12

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.42% 49.1% 570
Tuesday 0.14% 45.4% 626
Wednesday -0.14% 44.5% 623
Thursday -0.04% 48.2% 610
Friday 0.18% 46.5% 609

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 49.5%

Insider Transactions — Smart Summary

Total insider ownership: 1.0%

12-Month Insider Activity Summary

Total Filings8
Net Value+$91,638.96
Net Shares Change388,099
% of Float3.7%
C-Suite Filings6
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Rudick Richard Alan +$100,023.733 1 1 buy
Neermann Joerg +$76,700 1 1 buy
Whaley Glenn Chief Financial Officer +$32,076 1 1 buy
Vitt Daniel CEO and Director +$23,100 2 2 buy
Tardio Jason President and COO +$19,768.96 2 2 buy
Nash Duane Executive Chairman +$16,694 1 1 buy

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-06-04 – 2025-06-16 6 6 +$246,928.213 4 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-06-20 Tardio Jason President and COO +$9,884.48 Transaction at $0.79, now +1362.0%
2025-06-16 Nash Duane Executive Chairman +$16,694 Transaction at $0.83, now +1283.7%
2025-06-09 Tardio Jason President and COO +$9,884.48 Transaction at $0.79, now +1362.0%
2025-06-04 Whaley Glenn Chief Financial Officer +$32,076 Transaction at $0.71, now +1520.4%
2025-06-20 Vitt Daniel CEO and Director +$11,550 Transaction at $0.77, now +1400.0%
2025-06-06 Vitt Daniel CEO and Director +$11,550 Transaction at $0.77, now +1400.0%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Immunic Inc (IMUX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for IMUX on Trend Edge →